All lobbying filings
Ballard Partners
Ballard Partners filed a Q3 termination report for Biomerieux, Inc. on October 16, 2025, reporting $20,000 in lobbying income.
Lobbying for Biomerieux, Inc. · Medical technology company
Filing · LD-2 quarterly report
Q3 termination
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 16, 2025
Income
$20,000
What the client paid this registrant for the period.
Client based in
Utah
Representation ended
Jul 2, 2025
The registrant reported terminating its work for this client.
Lobbyists on this filing
1
-
JEFF MILLER Former member of CongressPreviously held: Former Member U.S. Congress
Government bodies contacted
1
Lobbying activity
1
Provide advocacy on issues related to bioMerieux and in vitro diagnostics.